Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMEN.L Regulatory News (MEN)

  • There is currently no data for MEN

Director Share Purchase

2 Apr 2024 15:02

RNS Number : 0141J
Molecular Energies PLC
02 April 2024
 

2 April 2024

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED) ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

MOLECULAR ENERGIES PLC

("Molecular" or the "Company")

 

Director Share Purchase

 

Molecular Energies plc (AIM: MEN), the international energy company, announces it has today been informed that on 2 April 2024, PLLG Investments Limited, a company wholly beneficially owned by Peter Levine, Chairman and largest shareholder in the Company, acquired 262,000 ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 7p per Ordinary Share (the "Share Purchase"). This reflects the statement made by Peter Levine in the Company's announcement of 28 March 2024 (the "Announcement") that he has "conviction in the value of Molecular as a whole" as a private enterprise and notwithstanding the proposed cancellation of the admission of the Ordinary Shares to trading on the AIM Market of the London Stock Exchange. Peter Levine reiterates the statement made in the Announcement that he "invite[s] any shareholders so minded to continue the journey alongside" but that "whilst making no commitment to do so, I do not rule out in the fullness of time and subject to de-listing and on becoming a private company making proposals to buy the shares of certain of those holders who either do not wish or are unable to be invested in a private business". Peter Levine is currently restricted from acquiring further Ordinary Shares without making a logistically burdensome general offer to all other shareholders since the Takeover Code continues to apply to the Company.

Following the Share Purchase, Peter Levine has a beneficial interest in 3,269,267 Ordinary Shares representing 26.41 per cent. of the issued share capital. Peter Levine and those acting in concert with him have combined beneficial interest in 3,705,981 Ordinary Shares representing 29.94 per cent. of the issued share capital.

 

Molecular Energies PLC

Peter Levine, Chairman

Rob Shepherd, Group FD

+44 (0)20 7016 7950

info@molecularenergiesplc.com

Cavendish Capital Markets Limited (Nominated Adviser & Broker)

Simon Hicks

George Dollemore

+44 (0)20 7220 0500

Tavistock (Financial PR & IR)

Simon Hudson, Nick Elwes, Saskia Sizen

+44 (0)20 7920 3150

 

 

For the purposes of MAR, Article 2 of Commission Implementing Regulation (EU) 2016/1055 and the UK version of such implementing regulation (as amended), the person responsible for arranging for the release of this Announcement on behalf of the Company is Peter Levine, Chairman.

 

Pursuant to the notification obligations in accordance with Article 19 of the Market Abuse Regulation (MAR)

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Peter Levine through PLLG Investments Limited

2.

Details of PDMR / person closely associated with them ('PCA')

a)

Position / status

Chairman

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Molecular Energies plc

b)

LEI

213800MA2ZN22I4ITA79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

c)

Description of the financial instrument

Ordinary shares of 1p each

ISIN: GB00B3DDP128

d)

Nature of the transaction

Purchase of Ordinary Shares

e)

Price and volume

Price (PENCE)

Volume

Peter Levine

 

7p

262,000

f)

Aggregated information

 

 Aggregated volume

 

 Price

 

 

 262,000 Ordinary Shares at 7p per Ordinary Share

 

g)

Date of the transaction

2 April 2024

h)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUURSRSRUSRAR
12
Date   Source Headline
29th Apr 20247:00 amRNSCancellation - Molecular Energies PLC
26th Apr 20247:00 amRNSLast Day of Dealing on AIM
22nd Apr 20246:00 pmRNSMolecular Energies
15th Apr 202411:44 amRNSResult of Meeting
2nd Apr 20243:02 pmRNSDirector Share Purchase
28th Mar 20247:00 amRNSCancellation of Listing
4th Mar 20247:00 amRNSStrategic progress in Green House Capital Group
1st Mar 20247:00 amRNSUpdate on Corporate and Trading Matters
30th Jan 20241:03 pmRNSHolding(s) in Company - Replacement
29th Jan 20246:00 pmRNSIssue of Equity
26th Jan 202410:59 amRNSHolding(s) in Company
24th Jan 20243:22 pmRNSResult of Fundraising
24th Jan 20247:00 amRNSFundraising
11th Jan 20247:00 amRNSCorporate and Business Update
18th Dec 20237:00 amRNSSignificant progress within Green House Capital
14th Dec 20237:00 amRNSParaguay Drilling Update
28th Nov 20237:00 amRNSAgreement signed between G-Mobility and CPH2
21st Nov 20237:00 amRNSResult of the Argentina Presidential Election
25th Oct 20237:00 amRNSStrategic Update
28th Sep 20237:00 amRNSUnaudited Interim Results for H1 2023
25th Sep 20237:00 amRNSAppointment of CEO of Green House Capital
21st Sep 20233:47 pmRNSResult of General Meeting
21st Sep 20237:00 amRNSCorporate Update
5th Sep 202312:00 pmRNSPosting of Circular and Notice of General Meeting
5th Sep 20237:00 amRNSProposed sale of President Energy Holding UK Ltd
31st Aug 20237:00 amRNSParaguay Drilling Update
16th Aug 20237:00 amRNSGreen House Capital Acquisition, Vehicle Test
7th Aug 20237:00 amRNSCorporate Update
26th Jul 20237:00 amRNSParaguay Update
25th Jul 20232:55 pmRNSResult of AGM
25th Jul 20239:56 amRNSHolding(s) in Company
17th Jul 20237:00 amRNSGreen House Capital Update
14th Jul 20237:00 amRNSSale of certain shares in Atome Energy PLC
30th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
28th Jun 20237:01 amRNSFinal Results
28th Jun 20237:00 amRNSPotential Spin Out of GHC
6th Jun 20237:00 amRNSQ1 Argentina Financial Results & Corporate Update
11th May 20237:00 amRNSParaguay Drilling Update
27th Apr 20237:00 amRNSBusiness Update
6th Apr 20234:00 pmRNSResult of General Meeting
20th Mar 20237:00 amRNSProposed Amendments to IYA Loan and Notice of GM
13th Mar 20237:00 amRNSCorporate and Operational Update
10th Feb 20234:40 pmRNSSecond Price Monitoring Extn
10th Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20237:00 amRNSParaguay Rig Update
26th Jan 20237:00 amRNSArgentina Operational Update
18th Jan 20237:00 amRNSExercise of Options and Total Voting Rights
9th Jan 20237:00 amRNSOperations and Strategic Update
5th Jan 20237:00 amRNSDuel Fuel Joint Venture
21st Dec 20222:10 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.